Trisalus Life Sciences

IPO

Home – Developing Treatments for Liver & Pancreatic Tumors

Public · Westminster, United States · Founded 2013 · $91.5M raised

Employees
51–200
Founded
2013
Business Model
B2B
Total Funding
$91.5M
Last Round
$12.8M Series DApr 2025
Rounds
5
Type
Public

About

Medical device company developing drug delivery technology for treating liver and pancreatic solid tumors.

Summary

Trisalus Life Sciences is a Healthcare company based in Westminster, United States, founded in 2013. It has raised $91.5M in total across 5 rounds, most recently a $12.8M Series D round in Apr 2025. Investors include Nantahala Capital.

Tech & App Stack

3 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Private EquityPrivate EquityApr 2025
$22.0M

Sign up to see all 6 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies